A Randomised, crossover, single-blind study to compare low-dose Ticagrelor (quarter or standard dose) with standard-dose clopidogrel in Chinese patients with stable coronary artery disease

Trial Profile

A Randomised, crossover, single-blind study to compare low-dose Ticagrelor (quarter or standard dose) with standard-dose clopidogrel in Chinese patients with stable coronary artery disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top